New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
08:25 EDTHEBHemispherx gains broad treatment expansion for Alferon N injection in Argentina
Hemispherx Biopharma, announced that ANMAT has approved the use of Alferon N Injection, under the brand name "Naturaferon", in Argentina for any patient that fails or becomes intolerant to treatment with recombinant interferon. Alferon N Injection is an FDA-approved natural interferon and, as Naturaferon, is already approved in Argentina for the treatment of refractory or recurring external condylomata acuminata.
News For HEB From The Last 14 Days
Check below for free stories on HEB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for HEB

Sign up for a free trial to see the rest of the stories you've been missing.